Relcovaptan

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRelcovaptan
Drug Alias Namerelcovaptanum瑞伐普坦瑞考伐坦瑞考伐普坦SR-49059
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1a receptor antagonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsDysmenorrheaSmall Cell Lung Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsDysmenorrheaSmall Cell Lung Carcinoma

Other Information

ATC CodeN/A
Related LinksWikipedia